---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-009916"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2022-04-14T23:59:59+00:00"
generated_at: "2026-06-26T07:21:55.573057+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MariMed gets Maryland approval to acquire Kind Therapeutics; over 139K patients in state program

## Summary
- MMCC approved transfer of 100% ownership of Kind Therapeutics to MariMed on April 13, 2022.
- Kind operates a cultivation/production facility in Hagerstown, MD and is developing a dispensary in Anne Arundel County.
- Maryland's medical cannabis program has over 139,000 patients and generated $500M+ in sales in 2021.
- Upon closing, Kind will become a wholly owned subsidiary, consolidating its financials with MariMed.
- MariMed (OTCQX: MRMD) expects to close the previously announced acquisition following this approval.

## SEC filing metadata
- accession: 0001493152-22-009916
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2022-04-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000149315222009916/0001493152-22-009916-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000149315222009916/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-009916
- JSON: https://secwatch.observer/filing/0001493152-22-009916.json
- Plain text: https://secwatch.observer/filing/0001493152-22-009916.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.